Clik here to view.
BioCision to Develop Customized ThawSTAR Automated Cell Thawing System for...
SAN RAFAEL, Calif. BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular...
View ArticleClik here to view.
Hanmi Pharmaceutical ‘HM61713’ Demonstrated the Effect of Tumor Volume Reduction
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd. (KSE:128940) presented the interim results of phase I/II domestic clinical trial on HM61713 at the 51st American Society of Clinical Oncology (ASCO)...
View ArticleClik here to view.
EYE TECH CARE Launches Its Operations in China as Part of Its International...
RILLIEUX-LA-PAPE, France EYE TECH CARE SA (ETC), a company developing and marketing equipment for non-invasive medical treatment in ophthalmology, today announced the launch of the approval process...
View ArticleClik here to view.
Novacyt and Leica Biosystems Launch NOVAprep® in China
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics and Leica Biosystems, a leading supplier to the pathology market,...
View ArticleClik here to view.
Columbia Pacific Management Invests in Orthopedic Hospital in Shanghai
SEATTLE Columbia Pacific Management – one of the largest healthcare providers in Asia, with 28 hospitals in India and Southeast Asia and three senior care facilities in China – announced today it is...
View ArticleClik here to view.
Astellas and Anokion to Collaborate on Immune Tolerance Therapeutics – Kanyos...
TOKYO & LAUSANNE, Switzerland Astellas Pharma Inc. (“Astellas”; TSE 4503, headquarters: Tokyo; President and CEO Yoshihiko Hatanaka) and Anokion SA (“Anokion“, headquarters: Lausanne; Chairman...
View ArticleClik here to view.
EYE TECH CARE Launches Its Operations in China as Part of Its International...
RILLIEUX-LA-PAPE, France EYE TECH CARE SA (ETC), a company developing and marketing equipment for non-invasive medical treatment in ophthalmology, today announced the launch of the approval process...
View ArticleClik here to view.
Stroke Prevention App Paves the Way for World-First Global Study
AUCKLAND, New Zealand Internationally praised app Stroke Riskometer™ will aim to reduce the cases of stroke and several other chronic diseases such as diabetes and heart disease by collecting and...
View ArticleClik here to view.
Latest Brainlab software for treatment of brain metastases and benign skull...
YOKOHAMA, Japan Experts in stereotactic radiosurgery (SRS) from all over the globe will be presenting Brainlab software innovations at this year’s International Stereotactic Radiosurgery Society...
View ArticleClik here to view.
エリテックがASCOでGRASPA®の第III相（ALL）の完全な結果を報告し、第IIb相（AML）の最新情報を提供
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（ADR:EYRYY）（Euronext Paris – ERYP; OTC US –...
View ArticleClik here to view.
World Glaucoma Congress to Feature Symposium on XEN Gel Stent for Minimally...
ALISO VIEJO, Calif. AqueSys, Inc., the developer of minimally invasive stent technology for the treatment of glaucoma, announced today it will host a XEN Gel Stent Symposium at the 6th Annual World...
View ArticleClik here to view.
Guided Therapeutics Awarded Multiple Tenders for LuViva® Advanced Cervical...
DHAKA, Bangladesh Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) announced today that its distributor in Bangladesh has been awarded contracts for four additional LuViva® Advanced Cervical...
View ArticleClik here to view.
DNAnexus Powers Research and Analysis of Rice Genomes to Help Feed World’s...
MOUNTAIN VIEW, Calif. DNAnexus Inc. announced today that its groundbreaking cloud-based genome informatics and data management platform is powering the 3000 Rice Genomes Project (3K RGP). The...
View ArticleClik here to view.
R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent...
TOKYO R-Tech Ueno (JASDAQ: 4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with Autonomous University of Barcelona (UAB) and Vall d’Hebron Institute of Research (VHIR),...
View ArticleClik here to view.
CEL-SCI is Cleared to Start Patient Enrollment for Its Phase 3 Cancer...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) (“CEL SCI” or the “Company”) today announced that CEL-SCI is now cleared to start patient enrollment in Thailand in its ongoing Phase 3 trial with its...
View ArticleClik here to view.
Allele Biotechnology & Pharmaceuticals Closes Purchase of cGMP Facility for...
SAN DIEGO Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”), a leader in the development of specialized cells for pharmaceutical drug discovery and regenerative medicine, today announced...
View ArticleClik here to view.
Allele Biotechnology & Pharmaceuticals完成对cGMP设施的收购，用于生产面向细胞疗法应用的临床级细胞
圣迭戈 (美国商业资讯) — Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”)是开发面向药品发现和再生医学的专用细胞的领先者，该公司今天宣布已完成对一处新设施的收购，用于其按现行药品生产质量管理规范(cGMP)生产面向细胞疗法应用的临床级细胞。...
View ArticleClik here to view.
Elekta CE Marks Leksell Gamma Knife® Icon™, designed to treat a more...
STOCKHOLM, Sweden Regulatory News: Elekta has CE marked its Leksell Gamma Knife® Icon™ (http://www.careforthebrain.com/) precision radiosurgery system, making this latest generation Leksell Gamma...
View ArticleClik here to view.
Oral Presentation Evaluating Pooled Data on OTEZLA® (apremilast) for...
BOUDRY, Switzerland Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that the findings from a long-term (104-week) post-hoc analysis of...
View ArticleClik here to view.
Annoroad and Illumina to Co-Develop NGS Diagnostic System for Reproductive...
BEIJING & SAN DIEGO Annoroad and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly develop advanced clinical applications for reproductive health based...
View Article